Site specific standard of care comparison ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
38	Stevens-Johnson syndrome	1
39	Toxic epidermal necrolysis	1

38. Stevens-Johnson syndrome

---

Clinical trials : 17 /  Drugs : 29 - (DrugBank : 9) / Drug target genes : 15 - Drug target pathways : 101

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03585946 (ClinicalTrials.gov)	January 1, 2021	14/3/2018	Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis	A Prospective Multicenter Cohort Study Assessing Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis	Stevens-Johnson Syndrome;Toxic Epidermal Necrolysis;Drug Reaction	Drug: Site specific standard of care comparison	Massachusetts General Hospital	NULL	Not yet recruiting	18 Years	N/A	All	750		NULL

39. Toxic epidermal necrolysis

---

Clinical trials : 13 /  Drugs : 19 - (DrugBank : 8) / Drug target genes : 11 - Drug target pathways : 103

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03585946 (ClinicalTrials.gov)	January 1, 2021	14/3/2018	Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis	A Prospective Multicenter Cohort Study Assessing Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis	Stevens-Johnson Syndrome;Toxic Epidermal Necrolysis;Drug Reaction	Drug: Site specific standard of care comparison	Massachusetts General Hospital	NULL	Not yet recruiting	18 Years	N/A	All	750		NULL